Live register
Drugs in short supply
1,181 products are currently reported in shortage to the FDA. Each row links to the manufacturer’s entry, so you can see what else they make and where. Most recently updated first; page 3 of 5. What changed this week / How many companies make each one.
| Drug | Manufacturer | Presentation | Availability | Updated |
|---|---|---|---|---|
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25) | Unavailable | 18 Sept 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25) | Unavailable | 18 Sept 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35) | Available | 18 Sept 26 |
| Promethazine Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25) | Limited Availability | 18 Sept 26 |
| Propranolol Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) | Unavailable | 18 Sept 26 |
| Remifentanil Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10) | Unavailable | 18 Sept 26 |
| Remifentanil Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10) | Available | 18 Sept 26 |
| Remifentanil Hydrochloride Injection | Hikma Pharmaceuticals USA, Inc. | Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10) | Unavailable | 18 Sept 26 |
| Rifampin Injection | Sanofi-Aventis U.S. LLC | Rifadin, Injection, 600 mg (NDC 0068-0597-01) | Unavailable | 18 Sept 26 |
| Rocuronium Bromide Injection | Hikma Pharmaceuticals USA, Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) | Available | 18 Sept 26 |
| Rocuronium Bromide Injection | Hikma Pharmaceuticals USA, Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) | Available | 18 Sept 26 |
| Rocuronium Bromide Injection | Sandoz Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) | Available | 18 Sept 26 |
| Rocuronium Bromide Injection | Sandoz Inc. | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) | Available | 18 Sept 26 |
| Rocuronium Bromide Injection | Sagent Pharmaceuticals | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) | Available | 18 Sept 26 |
| Sodium Acetate Injection | Hikma Pharmaceuticals USA, Inc. | Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01) | Available | 18 Sept 26 |
| Sodium Acetate Injection | Hikma Pharmaceuticals USA, Inc. | Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01) | Available | 18 Sept 26 |
| Sterile Water Injection | Hikma Pharmaceuticals USA, Inc. | Sterile Water, Injection, 1 mL/1 mL (NDC 0641-6147-10) | Available | 18 Sept 26 |
| Sufentanil Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02) | Unavailable | 18 Sept 26 |
| Sufentanil Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01) | Unavailable | 18 Sept 26 |
| Sufentanil Citrate Injection | Hikma Pharmaceuticals USA, Inc. | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05) | Unavailable | 18 Sept 26 |
| Technetium TC-99M Pyrophosphate Kit Injection | Sun Pharmaceutical Industries, Inc. | CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2) | Unavailable | 18 Sept 26 |
| Technetium TC-99M Pyrophosphate Kit Injection | Sun Pharmaceutical Industries, Inc. | CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1) | Unavailable | 18 Sept 26 |
| Valproate Sodium Injection | Hikma Pharmaceuticals USA, Inc. | Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10) | Available | 18 Sept 26 |
| Amino Acid Injection | Baxter Healthcare | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-03) | Available | 17 Sept 26 |
| Amino Acid Injection | Baxter Healthcare | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-04) | Available | 17 Sept 26 |
| Amino Acid Injection | Baxter Healthcare | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-06) | Available | 17 Sept 26 |
| Amino Acid Injection | Baxter Healthcare | Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-06) | Available | 17 Sept 26 |
| Amino Acid Injection | Baxter Healthcare | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-03) | Unavailable | 17 Sept 26 |
| Amino Acid Injection | Baxter Healthcare | Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-03) | Available | 17 Sept 26 |
| Amino Acid Injection | Baxter Healthcare | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-04) | Available | 17 Sept 26 |
| Amino Acid Injection | Baxter Healthcare | PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, Injection, 2.76 g/100 mL; 1.96 g/100 mL; 600 mg/100 mL; 1.02 g/100 mL; 2.06 g/100 mL; 1.18 g/100 mL; 1.08 g/100 mL; 1.08 g/100 mL; 1.35 g/100 mL; 760 mg/100 mL; 1 g/100 mL; 1.34 g/100 mL; 1.02 g/100 mL; 980 mg/100 mL; 320 mg/100 mL; 50 mg/100 mL; 1.44 g/100 mL (NDC 0338-0499-06) | Available | 17 Sept 26 |
| Amino Acid Injection | Baxter Healthcare | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-06) | Available | 17 Sept 26 |
| Azacitidine Injection | Eugia US LLC | Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) | Unavailable | 17 Sept 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50) | Available | 17 Sept 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10) | Available | 17 Sept 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50) | Available | 17 Sept 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30) | Available | 17 Sept 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30) | Available | 17 Sept 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10) | Available | 17 Sept 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30) | Available | 17 Sept 26 |
| Bupivacaine Hydrochloride Injection | Eugia US LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10) | Available | 17 Sept 26 |
| Carboplatin Injection | Eugia US LLC | Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01) | Available | 17 Sept 26 |
| Carboplatin Injection | Eugia US LLC | Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01) | Unavailable | 17 Sept 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50) | Available | 17 Sept 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50) | Unavailable | 17 Sept 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50) | Limited Availability | 17 Sept 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50) | Available | 17 Sept 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50) | Available | 17 Sept 26 |
| Clindamycin Phosphate Injection | Baxter Healthcare | Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50) | Available | 17 Sept 26 |
| Cromolyn Sodium Concentrate | Mylan Specialty, a Viatris Company | Gastrocrom, Concentrate, 20 mg/1 mL (NDC 0037-0678-96) | Available | 17 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Mylan Institutional, a Viatris Company | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30) | Available | 17 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Mylan Institutional, a Viatris Company | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12) | Available | 17 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Mylan Institutional, a Viatris Company | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54) | Available | 17 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Mylan Institutional, a Viatris Company | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10) | Available | 17 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Eugia US LLC | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25) | Available | 17 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Eugia US LLC | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02) | Available | 17 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Mylan Institutional, a Viatris Company | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50) | Available | 17 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Mylan Institutional, a Viatris Company | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02) | Available | 17 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Mylan Institutional, a Viatris Company | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10) | Available | 17 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24) | Available | 17 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Eugia US LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10) | Available | 17 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12) | Available | 17 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12) | Available | 17 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Eugia US LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10) | Available | 17 Sept 26 |
| Dextrose Monohydrate 10% Injection | Baxter Healthcare | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02) | Available | 17 Sept 26 |
| Dextrose Monohydrate 10% Injection | Baxter Healthcare | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03) | Available | 17 Sept 26 |
| Dextrose Monohydrate 10% Injection | Baxter Healthcare | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-18) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-03) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0078-20) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-9666-35) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-48) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-18) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-10) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-11) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-02) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-41) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0074-30) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-31) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 2.5 g/50 mL (NDC 0338-9664-40) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-11) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10) | Available | 17 Sept 26 |
| Dextrose Monohydrate 5% Injection | Baxter Healthcare | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-38) | Available | 17 Sept 26 |
| Dextrose Monohydrate 70% Injection | Baxter Healthcare | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06) | Limited Availability | 17 Sept 26 |
| Dobutamine Hydrochloride Injection | Baxter Healthcare | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02) | Available | 17 Sept 26 |
| Dobutamine Hydrochloride Injection | Baxter Healthcare | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02) | Available | 17 Sept 26 |
| Dobutamine Hydrochloride Injection | Baxter Healthcare | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02) | Available | 17 Sept 26 |
| Dopamine Hydrochloride Injection | Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) | Available | 17 Sept 26 |
| Dopamine Hydrochloride Injection | Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03) | Available | 17 Sept 26 |
| Dopamine Hydrochloride Injection | Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03) | Available | 17 Sept 26 |
| Dopamine Hydrochloride Injection | Baxter Healthcare | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02) | Available | 17 Sept 26 |
| Etomidate Injection | Mylan Institutional, a Viatris Company | Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) | Available | 17 Sept 26 |
| Etomidate Injection | Eugia US LLC | Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10) | Unavailable | 17 Sept 26 |
| Etomidate Injection | Eugia US LLC | Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20) | Unavailable | 17 Sept 26 |
| Etomidate Injection | Mylan Institutional, a Viatris Company | Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) | Available | 17 Sept 26 |
| Furosemide Injection | Baxter Healthcare | Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25) | Available | 17 Sept 26 |
| Furosemide Injection | Eugia US LLC | Furosemide, Injection, 100 mg/10 mL (NDC 55150-324-25) | Available | 17 Sept 26 |
| Furosemide Injection | Eugia US LLC | Furosemide, Injection, 40 mg/4 mL (NDC 55150-323-25) | Available | 17 Sept 26 |
| Furosemide Injection | Eugia US LLC | Furosemide, Injection, 20 mg/2 mL (NDC 55150-322-25) | Unavailable | 17 Sept 26 |
| Furosemide Injection | Baxter Healthcare | Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25) | Available | 17 Sept 26 |
| Furosemide Injection | Baxter Healthcare | Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25) | Available | 17 Sept 26 |
| Heparin Sodium Injection | Baxter Healthcare | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03) | Available | 17 Sept 26 |
| Heparin Sodium Injection | Baxter Healthcare | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04) | Available | 17 Sept 26 |
| Ifosfamide Injection | Baxter Healthcare | Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02) | Available | 17 Sept 26 |
| Ifosfamide Injection | Baxter Healthcare | Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01) | Available | 17 Sept 26 |
| Ifosfamide Injection | Baxter Healthcare | IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01) | Unavailable | 17 Sept 26 |
| Ifosfamide Injection | Baxter Healthcare | IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01) | Unavailable | 17 Sept 26 |
| Ketorolac Tromethamine Injection | Baxter Healthcare | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | Available | 17 Sept 26 |
| Ketorolac Tromethamine Injection | Baxter Healthcare | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | Unavailable | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30) | Available | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74) | Unavailable | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02) | Available | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05) | Available | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10) | Unavailable | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Baxter Healthcare | Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03) | Available | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05) | Unavailable | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50) | Unavailable | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02) | Unavailable | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10) | Unavailable | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20) | Unavailable | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Baxter Healthcare | Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02) | Available | 17 Sept 26 |
| Lidocaine Hydrochloride Injection | Eugia US LLC | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20) | Unavailable | 17 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77) | Available | 17 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77) | Available | 17 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77) | Available | 17 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77) | Available | 17 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77) | Available | 17 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77) | Available | 17 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Mylan Pharmaceuticals Inc., a Viatris Company | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77) | Available | 17 Sept 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Janssen Pharmaceuticals | Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01) | Available | 17 Sept 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Janssen Pharmaceuticals | Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01) | Available | 17 Sept 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Janssen Pharmaceuticals | Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01) | Available | 17 Sept 26 |
| Methylphenidate Hydrochloride Tablet, Extended Release | Janssen Pharmaceuticals | Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01) | Available | 17 Sept 26 |
| Methylprednisolone Acetate Injection | Eugia US LLC | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01) | Unavailable | 17 Sept 26 |
| Methylprednisolone Acetate Injection | Eugia US LLC | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01) | Unavailable | 17 Sept 26 |
| Metronidazole Injection | Baxter Healthcare | Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48) | Available | 17 Sept 26 |
| Remifentanil Hydrochloride Injection | Mylan Institutional, a Viatris Company | Ultiva, Injection, 2 mg (NDC 72078-035-02) | Available | 17 Sept 26 |
| Remifentanil Hydrochloride Injection | Mylan Institutional, a Viatris Company | Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01) | Available | 17 Sept 26 |
| Remifentanil Hydrochloride Injection | Mylan Institutional, a Viatris Company | Ultiva, Injection, 5 mg (NDC 72078-036-05) | Available | 17 Sept 26 |
| Rifampin Injection | Mylan Institutional, a Viatris Company | Rifampin, Injection, 600 mg (NDC 67457-445-60) | Unavailable | 17 Sept 26 |
| Rocuronium Bromide Injection | Baxter Healthcare | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) | Available | 17 Sept 26 |
| Rocuronium Bromide Injection | Eugia US LLC | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) | Available | 17 Sept 26 |
| Rocuronium Bromide Injection | Eugia US LLC | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) | Available | 17 Sept 26 |
| Rocuronium Bromide Injection | Baxter Healthcare | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) | Available | 17 Sept 26 |
| Rocuronium Bromide Injection | Mylan Institutional, a Viatris Company | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) | Available | 17 Sept 26 |
| Rocuronium Bromide Injection | Mylan Institutional, a Viatris Company | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) | Available | 17 Sept 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) | Unavailable | 17 Sept 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) | Unavailable | 17 Sept 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) | Available | 17 Sept 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) | Available | 17 Sept 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) | Available | 17 Sept 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) | Available | 17 Sept 26 |
| Ropivacaine Hydrochloride Injection | Eugia US LLC | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) | Available | 17 Sept 26 |
| Sterile Water Irrigant | Baxter Healthcare | Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-02) | Available | 17 Sept 26 |
| Sterile Water Irrigant | Baxter Healthcare | Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-04) | Limited Availability | 17 Sept 26 |
| Sterile Water Irrigant | Baxter Healthcare | Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-03) | Available | 17 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Oryza Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01) | Unavailable | 16 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Oryza Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01) | Unavailable | 16 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Oryza Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01) | Unavailable | 16 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Oryza Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01) | Unavailable | 16 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Oryza Pharmaceuticals Inc. | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01) | Unavailable | 16 Sept 26 |
| Atropine Sulfate Injection | Amphastar Pharmaceuticals, Inc. | Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1) | Available | 16 Sept 26 |
| Clonazepam Tablet | Cheplapharm Arzneimittel GmbH | Klonopin, Tablet, 2 mg (NDC 61269-620-10) | Available | 16 Sept 26 |
| Conivaptan Hydrochloride Injection | Cumberland Pharmaceuticals Inc. | Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10) | Unavailable | 16 Sept 26 |
| Cromolyn Sodium Concentrate | Micro Labs LTD | Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 42571-132-52) | Available | 16 Sept 26 |
| Desmopressin Acetate Spray | Apotex Corp. | Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0) | Available | 16 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10) | Available | 16 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10) | Available | 16 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08) | Available | 16 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08) | Available | 16 Sept 26 |
| Dextrose Monohydrate 50% Injection | Amphastar Pharmaceuticals, Inc. | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1) | Available | 16 Sept 26 |
| Dobutamine Hydrochloride Injection | Hainan Poly Pharm. Co., Ltd. | Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80) | Available | 16 Sept 26 |
| Lidocaine Hydrochloride Injection | Amphastar Pharmaceuticals, Inc. | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1) | Limited Availability | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1) | Unavailable | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Novadoz Pharmaceuticals LLC | Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Novadoz Pharmaceuticals LLC | Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Novadoz Pharmaceuticals LLC | Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Novadoz Pharmaceuticals LLC | Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Novadoz Pharmaceuticals LLC | Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91) | Available | 16 Sept 26 |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Novadoz Pharmaceuticals LLC | Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91) | Available | 16 Sept 26 |
| Lorazepam Injection | Amphastar Pharmaceuticals, Inc. | Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1) | Available | 16 Sept 26 |
| Morphine Sulfate Injection | Amphastar Pharmaceuticals, Inc. | Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1) | Available | 16 Sept 26 |
| Sodium Bicarbonate Injection | Amphastar Pharmaceuticals, Inc. | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1) | Limited Availability | 16 Sept 26 |
| Streptozocin Powder, For Solution | ESTEVE PHARMACEUTICALS, S.A. | Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01) | Available | 16 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Epic Pharma, LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 42806-341-01) | Limited Availability | 15 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Epic Pharma, LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 42806-345-01) | Limited Availability | 15 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Epic Pharma, LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 42806-344-01) | Limited Availability | 15 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Epic Pharma, LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 42806-343-01) | Limited Availability | 15 Sept 26 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Epic Pharma, LLC | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 42806-339-01) | Limited Availability | 15 Sept 26 |
| Atropine Sulfate Injection | Accord Healthcare Inc. | Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90) | Unavailable | 15 Sept 26 |
| Atropine Sulfate Injection | Accord Healthcare Inc. | Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45) | Available | 15 Sept 26 |
| Atropine Sulfate Injection | Medefil, Inc. | Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91) | Available | 15 Sept 26 |
| Atropine Sulfate Injection | Accord Healthcare Inc. | Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) | Unavailable | 15 Sept 26 |
| Azacitidine Injection | Accord Healthcare Inc. | Azacitidine, Injection, 100 mg (NDC 16729-306-10) | Available | 15 Sept 26 |
| Azacitidine Injection | Fresenius Kabi USA, LLC | Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) | Unavailable | 15 Sept 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31) | Unavailable | 15 Sept 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31) | Unavailable | 15 Sept 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57) | Available | 15 Sept 26 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31) | Unavailable | 15 Sept 26 |
| Carboplatin Injection | Gland Pharma Limited | Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01) | Limited Availability | 15 Sept 26 |
| Carboplatin Injection | Accord Healthcare Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34) | Unavailable | 15 Sept 26 |
| Carboplatin Injection | Accord Healthcare Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12) | Unavailable | 15 Sept 26 |
| Carboplatin Injection | Teva Pharmaceuticals USA, Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01) | Limited Availability | 15 Sept 26 |
| Carboplatin Injection | Gland Pharma Limited | Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01) | Unavailable | 15 Sept 26 |
| Carboplatin Injection | Accord Healthcare Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31) | Unavailable | 15 Sept 26 |
| Carboplatin Injection | Accord Healthcare Inc. | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33) | Unavailable | 15 Sept 26 |
| Carboplatin Injection | Fresenius Kabi USA, LLC | Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60) | Unavailable | 15 Sept 26 |
| Carboplatin Injection | Gland Pharma Limited | Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01) | Limited Availability | 15 Sept 26 |
| Carboplatin Injection | Gland Pharma Limited | Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01) | Available | 15 Sept 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, 1 mg (NDC 16729-137-00) | Available | 15 Sept 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, 2 mg (NDC 16729-138-00) | Available | 15 Sept 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, .5 mg (NDC 16729-136-00) | Available | 15 Sept 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, 1 mg (NDC 16729-137-16) | Available | 15 Sept 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, .5 mg (NDC 16729-136-16) | Available | 15 Sept 26 |
| Clonazepam Tablet | Accord Healthcare Inc. | Clonazepam, Tablet, 2 mg (NDC 16729-138-16) | Available | 15 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01) | Available | 15 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10) | Limited Availability | 15 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) | Limited Availability | 15 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01) | Available | 15 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30) | Available | 15 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10) | Available | 15 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) | Available | 15 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05) | Available | 15 Sept 26 |
| Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10) | Available | 15 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00) | Unavailable | 15 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95) | Available | 15 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20) | Unavailable | 15 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95) | Available | 15 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50) | Unavailable | 15 Sept 26 |
| Dexmedetomidine Hydrochloride Injection | Accord Healthcare Inc. | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93) | Unavailable | 15 Sept 26 |
For manufacturers
A shortage is a sourcing event.
Every product on this list is a molecule somebody urgently needs another source for. If you hold registered capacity for any of them, list it and we will route matching requests to you.
Provenance
Source: FDA drug shortage database via openFDA, refreshed daily. Note that the openFDA feed carries no reason-for-shortage field, so availability and therapeutic category are shown instead of a cause. Shortage status changes between refreshes; check the FDA database directly before acting on it clinically. This site is not affiliated with the FDA. Need shortage exposure joined to every NDC and manufacturer as a file? See the dataset.